Tianshui Zhongxing Bio-technologyLtd Yönetim

Yönetim kriter kontrolleri 3/4

Tianshui Zhongxing Bio-technologyLtd CEO'su Liang Liu, Mar2012 tarihinde atandı, in görev süresi 12.67 yıldır. şirketin hisselerinin 0.67% doğrudan sahiptir ve bu hisselerin değeri CN¥ 18.92M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 9.3 yıl ve 3.6 yıldır.

Anahtar bilgiler

Liang Liu

İcra Kurulu Başkanı

CN¥2.3m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	12.7yrs
CEO sahipliği	0.7%
Yönetim ortalama görev süresi	9.3yrs
Yönetim Kurulu ortalama görev süresi	3.6yrs

Son yönetim güncellemeleri

Recent updates

Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think

Nov 02

These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong

Oct 01

Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30

May 12

Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%

Mar 15

CEO

Liang Liu (50 yo)

12.7yrs

Görev süresi

CN¥2,331,800

Tazminat

Mr. Liang Liu serves as General Manager at Tianshui Zhongxing Bio-technology Co., Ltd February 25, 2016. He had been the Chief Financial Officer and Deputy General Manager of Tianshui Zhongxing Bio-technol...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Boshu Gao	Chairman	3.6yrs	CN¥2.32m	0.34% CN¥ 9.5m
Liang Liu	GM & Director	12.7yrs	CN¥2.33m	0.67% CN¥ 18.9m
Min Li	CFO & Financial Director	5.9yrs	CN¥1.40m	Veri yok
Bin Yuan	Deputy General Manager	no data	CN¥980.00k	0.50% CN¥ 14.1m
Jinjun Zhou	Deputy General Manager	4.7yrs	CN¥1.39m	0.025% CN¥ 704.0k

9.3yrs

Ortalama Görev Süresi

50yo

Ortalama Yaş

Deneyimli Yönetim: 002772 'un yönetim ekibi deneyimli ve deneyimlidir ( 9.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Boshu Gao	Chairman	3.6yrs	CN¥2.32m	0.34% CN¥ 9.5m
Liang Liu	GM & Director	12.7yrs	CN¥2.33m	0.67% CN¥ 18.9m
Lin Dang	Independent Director	2.8yrs	CN¥60.00k	Veri yok
Bo Zhao	Supervisor	3.6yrs	Veri yok	0.018% CN¥ 500.5k
Yufei Zhang	Director	3.6yrs	CN¥100.60k	Veri yok
Guoqing Wang	Director	3.6yrs	CN¥214.00k	Veri yok
Tianrong Zhang	Employee Representative Chairman of the Supervisory Committee	3.6yrs	Veri yok	Veri yok

3.6yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 002772 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.6 yıldır).

Tianshui Zhongxing Bio-technologyLtd Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Tianshui Zhongxing Bio-technology Co.,Ltd., Annual General Meeting, Apr 16, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think

Third quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.056 loss in 3Q 2023)

These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Second quarter 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.002 loss in 2Q 2023)

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report First Half, 2024 Results on Aug 16, 2024

Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30

Dividend of CN¥0.30 announced

Tianshui Zhongxing Bio-technology Co.,Ltd. Announces Dividend Implementation of 2023 Final Profit Distribution, Payable on 16 May 2024

First quarter 2024 earnings released: EPS: CN¥0.088 (vs CN¥0.50 in 1Q 2023)

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Tianshui Zhongxing Bio-technology Co.,Ltd., Annual General Meeting, Apr 16, 2024

Full year 2023 earnings released: EPS: CN¥0.39 (vs CN¥0.40 in FY 2022)

Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%

Investor sentiment improves as stock rises 19%

Investor sentiment deteriorates as stock falls 15%

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 26, 2024

Third quarter 2023 earnings released: CN¥0.056 loss per share (vs CN¥0.36 profit in 3Q 2022)

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report Q3, 2023 Results on Oct 28, 2023

Second quarter 2023 earnings released: CN¥0.002 loss per share (vs CN¥0.088 loss in 2Q 2022)

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report First Half, 2023 Results on Aug 19, 2023

Upcoming dividend of CN¥0.30 per share at 2.8% yield

Investor sentiment improves as stock rises 17%

Full year 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.14 in FY 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.16 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.088 loss per share (vs CN¥0.084 loss in 2Q 2021)

Tianshui Zhongxing Bio-Technology Co.,Ltd. Announces 2021 Final Profit Distribution Plan, Payable on 19 May 2022

Less than half of directors are independent

Tianshui Zhongxing Bio-technology Co.,Ltd. Approves Cash Dividend for 2021

Third quarter 2021 earnings released: CN¥0.16 loss per share (vs CN¥0.19 profit in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: CN¥0.084 loss per share (vs CN¥0.054 loss in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) signed a letter of intent to acquire Guizhou Moutai Shengjiao Wine Industry Co., Ltd. from Liu Liangyue.

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.22 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.56 (vs CN¥0.19 in FY 2019)

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 26, 2021

New 90-day low: CN¥8.86

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥11.30

New 90-day high: CN¥9.97

Third quarter earnings released

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report Q3, 2020 Results on Oct 22, 2020

Tianshui Zhongxing Bio-technology Co.,Ltd. to Report First Half, 2020 Results on Aug 22, 2020

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş